Tesamorelin TSM20 20mg*10vials

Tesamorelin TSM20 20mg x 10 Vials

Product Overview

Tesamorelin TSM20 is a high-concentration formulation in the TSM series of modified GHRH analog research peptides, representing an upgrade from TSM2, TSM5, and TSM10. Based on Tesamorelin classic optimized molecular modification framework, it retains core advantages such as enzyme resistance, stable GH and IGF-1 axis activation, and visceral-liver dual lipid-targeting properties. With its 20mg high-concentration formulation and enhanced molecular binding activity, TSM20 supports full-range lipolysis and endocrine remodeling efficacy research, exceeding the performance range of traditional 10mg upper-level Tesamorelin peptides. Designed for limit dose gradient threshold exploration, refractory severe visceral steatosis research, end-stage fatty liver metabolic reversal studies, extreme insulin resistance intervention research, and highly challenging peptide synergistic effect research, it serves as a core research material for high-threshold metabolic disorder mechanism research and extreme aging endocrine intervention preclinical projects.

Core Research Functions

Saturated Physiological Pulsatile GH Secretion and IGF-1 Peak Upregulation: Supports ultra-high amplitude saturated physiological pulsatile growth hormone secretion research and insulin-like growth factor-1 peak upregulation studies, comprehensively activating mitochondrial deep fat oxidation and metabolism, systemic lipid transport, and adipose tissue metabolic reprogramming pathway research.

Deep Visceral Fat Clearance and End-Stage Liver Lipid Deposition Intervention: Supports stubborn deep visceral fat thorough clearance research and end-stage liver lipid deposition reversal studies.

Severe Adipose Tissue Inflammation Alleviation and Insulin Signaling Resistance Intervention: Supports severe adipose tissue inflammation comprehensive alleviation research and extreme insulin signaling resistance intervention studies.

Endocrine Repair and Lean Tissue Proliferation Regulation: Supports high-intensity endocrine repair research and high-density lean tissue proliferation regulation studies, maximizing modified GHRH peptide physiological anti-aging and body composition remodeling potential research.

Natural Physiological Pulsed Activation Logic Adherence: Supports natural physiological pulsed activation logic adherence research, feedback inhibition and long-term receptor desensitization related studies under high-concentration long-term intervention, and stable endocrine homeostasis maintenance research.

TSM20 efficacy exceeds TSM10, achieving superior efficacy in core research dimensions. It supports refractory metabolic disorder intervention research that shows limited response to conventional medium-to-high dose regimens, including severe central obesity, advanced metabolic-related fatty liver, and refractory lipid metabolism disorders. TSM20 is suitable for extreme mechanism research, high-dose gradient threshold screening, and highly complex peptide protocol validation, providing high-discrimination full-saturation reproducible experimental data for endocrine intervention mechanism in-depth exploration in refractory metabolic syndrome and extreme aging research.

Core Product Advantages

TSM20 High-Concentration Flagship Product: The highest-specification product in the TSM series, exceeding the traditional 10mg concentration limit. With enhanced molecular target affinity and pathway activation efficiency, it achieves advanced intervention performance of modified Tesamorelin peptides, designed for high-threshold scientific research.

Visceral and Liver Lipid Clearance: Building upon the efficacy of TSM10, it further supports deep lipid pathway activation maximization research, achieving stubborn visceral fat and end-stage liver lipid deposits clearance research. It provides research capabilities for refractory and severe metabolic disorder interventions that exceed traditional formulation coverage ranges.

Enhanced Stable Modified Molecular Structure: Upgraded optimized structural modification technology supports anti-degradation and anti-metabolic stability research. It supports high-intensity long-term chronic extreme metabolic intervention research, outputting continuous stable high-amplitude metabolic regulatory signals, supporting hormonal fluctuations and endocrine interference related studies, ensuring stable long-term experimental data research capabilities.

20mg High-Concentration Specification: The concentration and efficacy are twice that of TSM10, four times that of TSM5, and ten times that of TSM2. It is a high-dose extreme research specification, suitable for super-gradient threshold exploration research scenarios, refractory and severe metabolic disease intervention research, and highly complex peptide synergistic effect research.

Pharmaceutical-Grade High-Purity Premium Product: Utilizing fully locked vacuum freeze-drying technology, it supports high peptide peak activity stable retention research. Each batch undergoes comprehensive HPLC high-purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term stable activity maintenance, it is suitable for advanced laboratory research, key scientific research projects, and customized bulk procurement.

Specifications and Quality Control

Format: Lyophilized powder, 20mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).